Difference between revisions of "Profiles"
Jump to navigation
Jump to search
Line 13: | Line 13: | ||
*[[Media:QIBA_fMRI_Profile_1_PC.pdf| QIBA fMRI Profile 2017-06-19]] ''Public Comment to open on June 19, 2017'' | *[[Media:QIBA_fMRI_Profile_1_PC.pdf| QIBA fMRI Profile 2017-06-19]] ''Public Comment to open on June 19, 2017'' | ||
− | *[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] ''Public Comment is open | + | *[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] ''Public Comment is open until September 15, 2017'' |
− | * [[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| DWI Profile 2017-04-27]] | + | * [[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| DWI Profile 2017-04-27]] ''Public Comment is open until July 28, 2017'' |
* [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'') | * [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'') | ||
*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016]] | *[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016]] |
Revision as of 21:00, 15 June 2017
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
Link to QIBA Public Comment Form: http://tinyurl.com/y8dy2pc2
- QIBA fMRI Profile 2017-06-19 Public Comment to open on June 19, 2017
- QIBA PET Amyloid Profile 2017-06-15 Public Comment is open until September 15, 2017
- DWI Profile 2017-04-27 Public Comment is open until July 28, 2017
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
- Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)